ANTIBE THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.295 CAD | 0.00% |
|
0.00% | -68.28% |
| Apr. 24 | Antibe Therapeutics Inc. Announces Board Resignations | CI |
| Apr. 19 | Antibe Therapeutics Seeks Extension of Stay of Proceedings | MT |
Chart calendar Antibe Therapeutics Inc.
6fc1da0c7822f11db9246b.VTkuUh_9BX6289K1x6q7a1JPuwmIQTorjL9sWsDdQ1o.YmF3KEnNUTbVu7bytdPIOhg_1H3gBglP5-dVGLSYCxQ5AHkReZk9DunB4g~cec8851e8ca067484f6feeee39b463ae
Upcoming events on Antibe Therapeutics Inc.
Past events on Antibe Therapeutics Inc.
| 2024-04-17 11:00 am | Bloom Burton & Co. Healthcare Investor Conference |
| 2024-03-21 11:15 am | Regional Anesthesiology and Acute Pain Medicine Meeting |
| 2024-03-08 05:30 pm | American Academy of Pain Medicine Meeting |
| 2024-02-14 06:23 am | Q3 2024 Earnings Release |
| 2023-11-13 06:31 am | Q2 2024 Earnings Release |
| 2023-09-08 10:00 am | Annual General Meeting |
| 2023-08-14 07:00 am | Q1 2024 Earnings Release |
| 2023-06-29 07:30 am | Q4 2023 Earnings Release |
| 2023-05-02 12:00 pm | Precision in Clinical Trials Summit |
| 2023-04-26 01:30 pm | Bloom Burton & Co Healthcare Investor Conference |
| 2023-02-14 07:04 pm | Q3 2023 Earnings Release |
| 2022-11-14 06:10 pm | Interim 2023 Earnings Release |
| 2022-09-08 09:30 pm | PAINWeek National Conference |
| 2022-09-08 | Annual General Meeting |
| 2022-08-15 07:00 am | Q1 2023 Earnings Release |
| 2022-06-29 10:27 pm | FY 2022 Earnings Release |
| 2022-05-03 02:00 pm | Bloom Burton & Co. Healthcare Investor Conference |
| 2022-02-14 07:00 am | Q3 2022 Earnings Release |
| 2021-11-15 08:20 pm | Interim 2022 Earnings Release |
| 2021-09-13 07:00 am | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 9,54 9,30 2.57% | 9,99 10,1 -0.91% | 9,70 13,0 -25.6% | 13,5 3,83 252.45% | 0,00 0,00 - | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -11,8 -7,36 -60.01% | -13,7 -9,80 -39.62% | -23,8 -17,6 -34.89% | -19,9 -15,9 -25.32% | -17,7 -20,8 14.73% | -22,3 |
|
EBIT Million CAD | Released Forecast Spread | -12,2 -9,50 -28.29% | -17,6 -15,6 -13.04% | -24,3 -23,0 -5.65% | -25,5 -28,0 8.76% | -20,5 -23,3 11.81% | -20,8 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -12,7 -10,1 -25.56% | -19,3 -16,3 -18.71% | -24,7 -23,9 -3.47% | -25,3 -26,7 5.32% | -19,3 -20,8 7.13% | -19,5 |
|
Net income Million CAD | Released Forecast Spread | -12,8 -10,1 -26.89% | -19,3 -16,2 -19.04% | -26,3 -20,9 -25.57% | -25,1 -26,0 3.48% | -19,5 -23,0 15.22% | -19,5 |
|
EPS CAD | Released Forecast Spread | -0,60 -0,50 -20% | -0,70 -0,60 -16.67% | -0,70 -0,57 -23.12% | -0,50 -0,51 1.7% | -0,37 -0,40 7.5% | -0,37 |
| Announcement Date | 16/07/19 | 24/07/20 | 28/06/21 | 29/06/22 | 29/06/23 | - |
Quarterly results
| Fiscal Period | March | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 3,97 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -3,76 -3,30 -13.97% | -4,71 -3,70 -27.16% | -5,05 -4,10 -23.24% | -5,70 -4,25 -34.12% | -3,85 -5,55 30.58% | -3,13 -6,20 49.5% | -5,86 -5,50 -6.62% | -5,53 -5,80 4.67% | -4,15 -5,80 28.38% | |||||
|
EBIT Million CAD | Released Forecast Spread | -5,23 -7,71 32.14% | -5,45 -7,24 24.72% | -5,80 -6,06 4.37% | -6,51 -6,09 -6.9% | -4,66 -6,68 30.18% | -3,58 -6,32 43.34% | -6,28 -4,17 -50.53% | -5,45 -6,42 15.1% | -4,60 -7,39 37.79% | -4,51 | -4,18 | -3,90 | -3,69 | -3,50 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -5,22 -6,99 25.34% | -5,29 -6,71 21.28% | -5,60 -5,72 2.14% | -6,25 -5,94 -5.21% | -4,21 -7,03 40.2% | -3,24 -7,06 54.15% | -5,79 -4,17 -38.69% | -5,01 -6,42 22% | -4,21 -6,05 30.39% | -4,51 | -4,18 | -3,90 | -3,69 | -3,50 |
|
Net income Million CAD | Released Forecast Spread | -4,85 -7,07 31.39% | -5,24 -6,62 20.87% | -5,50 -5,72 3.9% | -6,08 -5,94 -2.36% | -4,32 -7,03 38.62% | -3,55 -7,06 49.73% | -5,79 -4,17 -38.69% | -5,01 -6,42 22% | -4,21 -6,05 30.39% | -4,51 | -4,18 | -3,90 | -3,69 | -3,50 |
|
EPS CAD | Released Forecast Spread | -0,09 -0,14 34.9% | -0,11 -0,13 14.06% | -0,10 -0,11 8.42% | -0,12 -0,11 -7.33% | -0,08 -0,13 36.61% | -0,07 -0,12 41.67% | -0,11 -0,10 -15.79% | -0,10 -0,12 16.67% | -0,08 -0,12 30.43% | -0,09 | -0,08 | -0,07 | -0,07 | -0,07 |
| Announcement Date | 14/02/22 | 29/06/22 | 15/08/22 | 14/11/22 | 14/02/23 | 29/06/23 | 14/08/23 | 13/11/23 | 14/02/24 | - | - | - | - | - |
More events
Past sector events for Antibe Therapeutics Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ATE Stock
- Calendar Antibe Therapeutics Inc.
